Sun and colleagues [46] recently reported that CD34+ stem cells from patients with SLE had abnormal expression of CD166 and CD123 and that these abnormalities correlated with the overall lupus disease activity. The gene discussed is ALCAM; the disease is systemic lupus erythematosus.